CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer

Anticancer Research

Volumn 30, Issue 1, 2010, Pages 239-244

  Tahara, Tomomitsu ^a   Shibata, Tomoyuki ^a   Arisawa, Tomiyasu ^b   Nakamura, Masakatsu ^a   Yamashita, Hiromi ^a   Yoshioka, Daisuke ^a   Okubo, Masaaki ^a   Yonemura, Joh ^a   Maeda, Yoshiteru ^a   Maruyama, Naoko ^a   Kamano, Toshiaki ^a   Kamiya, Yoshio ^a   Fujita, Hiroshi ^a   Nakagawa, Yoshihito ^a   Nagasaka, Mitsuo ^a   Iwata, Masami ^a   Hirata, Ichiro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

CpG island hypermethylation; Gastric cancer; Morphological appearance

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; PROTEIN P14; PROTEIN P16; UVOMORULIN;

ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CELL STRUCTURE; CPG ISLAND; DISTANT METASTASIS; DNA METHYLATION; EARLY CANCER; FEMALE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CANCER; STOMACH ULCER; TUMOR SUPPRESSOR GENE;

AGED; APOPTOSIS REGULATORY PROTEINS; CADHERINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CPG ISLANDS; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 77649241211     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rizos H, Darmanian AP, Mann GJ and Kefford RF: Two arginine-rich domains in the p14 ARF tumour suppressor mediate nucleolar localization. Oncogene 19: 2978-2985, 2000.
2. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J and Wittekind C: INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene 20: 7104-7109, 2001.
3. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB and Issa JP: Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59: 5438-5442, 1999.
4. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY and Rhyu MG: CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61: 2847-2851, 2001.
5. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A and Kwong YL: Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52: 502-506, 2003.
6. Raveh T and Kimchi A: DAP kinase - a proapoptotic gene that functions as a tumor suppressor. Exp Cell Res 264: 185-192, 2001.
7. Schildhaus HU, Krockel I, Lippert H, Malfertheiner P, Roessner A and Schneider-Stock R: Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. Int J Oncol 26: 1493-1500, 2005.
8. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S and Motoyama T: Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 94: 360-364, 2003.
9. Munot K, Bell SM, Lane S, Horgan K, Hanby AM and Speirs V: Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum Pathol 37: 989-999, 2006.
10. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999.
11. Marsit CJ, Houseman EA, Christensen BC, Eddy K, Bueno R, Sugarbaker DJ, Nelson HH, Karagas MR and Kelsey KT: Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res 66: 10621-10629, 2006.
12. Shen L, Ahuja N, Shen Y, Habib NA, Toyota M, Rashid A and Issa JP: DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 94: 755-761, 2002.
13. Murray CJ and Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349: 1269-1276, 1997.
14. Parkin DM, Bray F, Ferlay J, Pisani P: 2 Parkin DM, Bray F, Ferlay J and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001.
15. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
16. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T and Kato Y: Incidence of lymph node metastasis from early gastric cancenestimation with a large number of cases at two large centers. Gastric Cancer 3: 219-225, 2000.
17. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB and Herman JG: Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60: 129-133, 2000.
18. Herman JG, Graff JR, Myöhänen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
19. Katzenellenbogen RA, Baylin SB and Herman JG: Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 93: 4347-4353, 1999.
20. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH and Kim JS: Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 163: 1551-1556, 2003.
21. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M and Ushijima T: High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989-995, 2006.
22. Tahara T, Arisawa T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Takahama K, Watanabe M, Yamashita H and Hirata I: Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis. Eur J Gastroenterol Hepatol 21: 613-619, 2009.
23. Issa JP: GpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 249: 101-118, 2000.
24. Meyer-ter-Vehn T, Covacci A, Kist M and Pahl HL: Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem 275: 16064-16072, 2000.
25. Kwon SJ and Lee GJ: Clinicopathologic characteristics of Borrmann type IV gastric cancer. J Korean Surg Soc 64: 127-133, 2003.
26. Kim DY, Kim HR, Kim YJ and Kim S: Clinicopathological features of patients with Borrmann type IV gastric carcinoma. J Surg 72: 739-742, 2002.
27. Otsuji E, Kuriu Y, Okamoto K, Ochiai T, Ichikawa D, Hagiwara A and Yamagishi H: Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg 188: 327-332, 2004.
28. Yook JH, Oh ST and Kim BS: Cliniopathological analysis of Borrmann type IV gastric cancer. Cancer Res Treat 37: 87-91, 2005.
29. Kodera Y, Yamamura Y, Ito S, Kanemitsu Y, Shimizu Y, Hirai T, Yasui K and Kato T: Is Borrmann type IV gastric carcinoma a surgical disease? An old problem revisited with reference to the result of peritoneal washing cytology. J Surg Oncol 78: 175-181 (discussion 181-172), 2001.
30. Zhang KL, Sun Y, Li Y, Liu M, Qu B, Cui SH, Kong QY, Chen XY, Li H and Liu J: Increased frequency of CpG island methylator phenotype and CDH1 methylation in a gastric cancer high-risk region of china. Transl Oncol 1: 28-35, 2008.
31. Yi Kim D, Kyoon Joo J, Kyu Park Y, Yeob Ryu S, Soo Kim H, Kyun Noh B, Hwa Lee K and Hyuk Lee J: E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis. J Surg Oncol 96: 429-435, 2007.
32. Luo D, Zhang B, Lv L, Xiang S, Liu Y, Ji J and Deng D: Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas. Lab Invest 86: 591-598, 2006.